Healthcare Policy

Pharmaceutical Regulation Drug Pricing Emergency Response Affordable Care Act Pharmaceutical Oversight Private Equity Oversight Public Safety Medical Device Approval Reproductive Health Cannabis Regulation Infant Health Opioid Regulation FDA Pricing Guidelines

3 ARTICLES

last mo.

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

The pharmaceutical giant will build seven new facilities and a $1.1 billion research hub in San Diego, aiming to bolster domestic drug production and create thousands of jobs.

5 ARTICLES

2mo ago

China Matches Neuralink with BCI Implants, Sets $902 Pricing for Procedures

4 ARTICLES

2mo ago

Purdue Pharma Proposes $7.4 Billion Settlement Plan for Opioid Crisis Lawsuits

3 ARTICLES

2mo ago

Judge Orders Retrial in Premature Infant Formula Case Involving Abbott and Reckitt

4 ARTICLES

3mo ago

FTC Sues Top Pharmacy Benefit Managers Over Inflated Insulin Prices

Healthcare Policy

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

China Matches Neuralink with BCI Implants, Sets $902 Pricing for Procedures

Purdue Pharma Proposes $7.4 Billion Settlement Plan for Opioid Crisis Lawsuits

Judge Orders Retrial in Premature Infant Formula Case Involving Abbott and Reckitt

Germany's Cannabis Imports Quadrupled in 2024, Driven by Online Prescriptions

Trump IVF Executive Order Divides GOP and Raises Ethical Concerns

FDA Proposes New Standards for Pulse Oximeters to Address Skin Tone Bias

Blinkit Launches 10-Minute Ambulance Service in Gurgaon

FTC Sues Top Pharmacy Benefit Managers Over Inflated Insulin Prices